Dr G Gordon Snyder Iii, MD in Bloomfield, CT - Otolaryngology

Dr G Gordon Snyder Iii, MD is a Otolaryngology physician based in Bloomfield, Connecticut. Dr G Gordon Snyder Iii is licensed to practice in Connecticut (license number 15262) and his current practice location is 701 Cottage Grove Rd, A-230, Bloomfield, Connecticut. He can be reached at his office (for appointments etc.) via phone at (860) 242-5274.

NPI number for Dr G Gordon Snyder Iii is 1720189509 and his current mailing address is 701 Cottage Grove Rd, A-230, Bloomfield, Connecticut. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1720189509.

Contact Information

	Dr G Gordon Snyder Iii, MD
	701 Cottage Grove Rd, A-230, Bloomfield, CT 06002-3080
	(860) 242-5274
	(860) 242-3643

Physician's Profile

Full Name	Dr G Gordon Snyder Iii
Gender	Male
Speciality	Otolaryngology
Location	701 Cottage Grove Rd, Bloomfield, Connecticut
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1720189509
Provider Enumeration Date: 09/26/2006
Last Update Date: 06/21/2010

Medical Identifiers

Medical identifiers for Dr G Gordon Snyder Iii such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1720189509	NPI	-	NPPES
001152628	Medicaid	CT
040000101	Other		MEDICARE PTAN

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Y00000X	Otolaryngology	15262 (Connecticut)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr G Gordon Snyder Iii is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr G Gordon Snyder Iii, MD 701 Cottage Grove Rd, A-230, Bloomfield, CT 06002-3080 Ph: (860) 242-5274	Dr G Gordon Snyder Iii, MD 701 Cottage Grove Rd, A-230, Bloomfield, CT 06002-3080 Ph: (860) 242-5274

News Archive

Agios announces data from dose-escalation phase 1 study of AG-120 in patients with IDH1 mutant positive advanced solid tumors

Agios Pharmaceuticals, Inc., a leader in the fields of cancer metabolism and rare genetic metabolic disorders, today announced the first data from the dose-escalation portion of the ongoing Phase 1 study evaluating single agent AG-120, a first-in-class, oral, selective, potent inhibitor of mutant isocitrate dehydrogenase-1 (IDH1), in advanced solid tumors. The data are being presented today at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston. AG-120 is being developed in collaboration with Celgene.

Epidemiologic and physiologic research on sedentary behavior

Lack of physical exercise is often implicated in many disease processes. However, sedentary behavior, or too much sitting, as distinct from too little exercise, potentially could be a new risk factor for disease.

The $60,900,000 Washington Health Care Facilities Authority variable rate revenue bonds, series 2002B are rated F1+ by Fitch

Fitch Ratings assigns an 'F1+' short-term rating to the $60,900,000 Washington Health Care Facilities Authority variable rate revenue bonds, series 2002B (Catholic Health Initiatives). The short-term 'F1+' rating is based on the liquidity support of a standby bond purchase agreement (SBPA) provided by JPMorgan Chase Bank, N.A. The long-term rating (currently 'AA') continues to be based on the rating assigned to the Catholic Health Initiatives revenue bonds.

Study finds link between meditation, the endocrine system, health and wellbeing

New collaborative research at Queen's University Belfast and Victoria University, Melbourne, Australia aims to better understand the link between meditation and improved mental health outcomes.

Mutations in gene protecting body leads to development of cancer

An important gene that normally protects the body against cancer can itself cause a variety of cancers depending on the specific mutation that damages it, according to a new study by investigators at the Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James).

Otolaryngology Doctors in Bloomfield, CT

Sheldon Nova, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 4 Northwestern Dr, Suite 300, Bloomfield, CT 06002 Phone: 860-243-8997 Fax: 860-769-6803
Ronald J Saxon, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 4 Northwestern Dr, Suite 300, Bloomfield, CT 06002 Phone: 860-243-8997 Fax: 860-769-6803
Stephen George Wolfe, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4 Northwestern Dr, Suite 300, Bloomfield, CT 06002 Phone: 860-243-8997

Dr G Gordon Snyder Iii, MD - Otolaryngology in Bloomfield, CT